Ophir Klein
Executive Director of Cedars-Sinai Guerin Children's · University of California (San Diego) Medical Center
Credentials: · · ·
History
- 2000–2003
Pediatrics
1996–2000
Research
A reserve stem cell population in small intestine renders Lgr5-positive cells dispensable
Nature · 2011 · 986 citations
In vitro generation of human pluripotent stem cell derived lung organoids
eLife · 2015 · 644 citations
The branching programme of mouse lung development
Nature · 2008 · 579 citations
8 papers
- SO
8 papers
6 papers
6 papers · 4 as a resident
- MD
5 papers
- PC
5 papers
- RN
5 papers
4 papers
Grants
- 2025–2030
A Team Science Approach to the Co Development of Oral Mucosa for Therapeutic Purposes
National Institute of Dental and Craniofacial Research · RM1
Contact PI · $2.4M · Cedars-Sinai Medical Center
- 2025–2030
Mechanisms of Hyperactive Ras Signaling in Craniofacial and Dental Diseases
National Institute of Dental and Craniofacial Research · R01
Contact PI · $1.2M · Cedars-Sinai Medical Center
- 2024–2029
Consortium on Intestinal Regeneration and Fetal Reversion: From Atlas to Therapy
National Institute of Diabetes and Digestive and Kidney Diseases · RC2
Contact PI · $6M · Cedars-Sinai Medical Center
- 2025–2027
Developmental and Molecular Basis for a Craniofacial Metabolic Syndrome
National Institute of Dental and Craniofacial Research · R21
PI · $464.5K · University of California, San Francisco
Clinical trials
- 2012–2013
A Phase 1, Open-label, Multicenter, Safety and Pharmacokinetic Study of EDI200
Principal investigator · Completed · Phase 1
Edimer Pharmaceuticals
- 2011
Principal investigator · Completed
Edimer Pharmaceuticals